Please find enclosed the Press Release

Globalspace Technologies has launched a new AI-based product called PATGPT, a Pharma-specific Large Language Model (LLM) platform, on September 23, 2025. PATGPT is offered as a SaaS/digital solution targeted at pharmaceutical enterprises in the domestic market. It uses a hybrid training model where 50% of training is done on pharma datasets by Globalspace and the remaining 50% is trained on each pharma company's proprietary data within their secure cloud environment. Initially, PATGPT will focus on sales, marketing, inventory, and distribution optimization, with future plans to expand into R&D, clinical trials, pharmacovigilance, and regulatory submissions.